Home › Compare › SAVAW vs EPRT

SAVAW vs EPRT: Dividend Comparison 2026

SAVAW yields 6666.67% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SAVAW wins by $1028095347812062.00M in total portfolio value
10 years
SAVAW
SAVAW
● Live price
6666.67%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1028095347812062.00M
Annual income
$998,628,545,336,266,700,000.00
Full SAVAW calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — SAVAW vs EPRT

📍 SAVAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSAVAWEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SAVAW + EPRT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SAVAW pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAVAW
Annual income on $10K today (after 15% tax)
$566,666.67/yr
After 10yr DRIP, annual income (after tax)
$848,834,263,535,826,600,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, SAVAW beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAVAW + EPRT for your $10,000?

SAVAW: 50%EPRT: 50%
100% EPRT50/50100% SAVAW
Portfolio after 10yr
$514047673906031.00M
Annual income
$499,314,272,668,133,360,000.00/yr
Blended yield
97.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

SAVAW
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAVAW buys
0
EPRT buys
0
No recent congressional trades found for SAVAW or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSAVAWEPRT
Forward yield6666.67% ✓3.97%
Annual dividend / share$2.00 ✓$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29% ✓
Portfolio after 10y$1028095347812062.00M ✓$64.3K
Annual income after 10y$998,628,545,336,266,700,000.00 ✓$13,170.85
Total dividends collected$1026118102492338.88M ✓$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SAVAW vs EPRT ($10,000, DRIP)

YearSAVAW PortfolioSAVAW Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$677,367$666,666.67$11,212$512.01+$666.2K → SAVAW
2$42,928,313$42,203,530.63$12,689$692.09+$42.92M → SAVAW
3$2,545,616,701$2,499,683,405.64$14,521$944.30+$2545.60M → SAVAW
4$141,255,910,403$138,532,100,533.89$16,841$1,302.88+$141255.89M → SAVAW
5$7,335,374,338,812$7,184,230,514,680.15$19,841$1,821.64+$7335374.32M → SAVAW
6$356,516,885,536,661$348,668,034,994,132.70$23,818$2,587.47+$356516885.51M → SAVAW
7$16,218,956,689,966,618$15,837,483,622,442,392.00$29,230$3,744.65+$16218956689.94M → SAVAW
8$690,711,023,145,868,900$673,356,739,487,604,600.00$36,816$5,540.38+$690711023145.83M → SAVAW
9$27,539,067,734,387,980,000$26,800,006,939,621,900,000.00$47,806$8,413.17+$27539067734387.93M → SAVAW
10$1,028,095,347,812,062,000,000$998,628,545,336,266,700,000.00$64,324$13,170.85+$1028095347812062.00M → SAVAW

SAVAW vs EPRT: Complete Analysis 2026

SAVAW — Stock

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

Full SAVAW Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this SAVAW vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAVAW vs SCHDSAVAW vs JEPISAVAW vs OSAVAW vs KOSAVAW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.